| Streptococcus pneumoniae (NORTHCENTRAL Data) | |||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
| penicillin | 77.7% n=139 | 84.6% n=104 | 67.9% n=53 | 80% n=45 | 68.3% n=41 | 80.3% n=66 | |
| amoxicillin/clavulanate | 94.3% n=70 | 97.5% n=79 | 89.5% n=19 | 100% n=16 | |||
| ampicillin | 97.5% n=79 | 100% n=28 | |||||
| vancomycin | 100% n=89 | 100% n=104 | 100% n=24 | 100% n=45 | 100% n=39 | 100% n=82 | |
| cefaclor | 71.4% n=70 | 81% n=79 | |||||
| cefuroxime | 74.3% n=70 | 92.4% n=79 | 63.2% n=19 | 81.3% n=16 | |||
| cefotaxime | 100% n=70 | 95.8% n=24 | 100% n=45 | 94.7% n=19 | 100% n=16 | ||
| ceftriaxone | 97.4% n=114 | 88% n=25 | 95.8% n=24 | 100% n=45 | 95% n=60 | 100% n=16 | |
| clindamycin | 86.7% n=45 | 87% n=54 | 86.6% n=82 | ||||
| erythromycin | 68.5% n=89 | 61.5% n=104 | 73.6% n=53 | 77.8% n=45 | 63.4% n=41 | 60.6% n=66 | |
| azithromycin | 57.1% n=70 | 68.4% n=79 | 52.6% n=19 | 68.8% n=16 | |||
| levofloxacin | 100% n=89 | 99% n=104 | 100% n=53 | 98.6% n=73 | 94.9% n=39 | 96.3% n=82 | |
| gatifloxacin | 100% n=74 | 98.7% n=79 | |||||
| TMP/SMX | 84.3% n=89 | 80.8% n=104 | 73.6% n=53 | 73.3% n=45 | 66.7% n=60 | 72% n=82 | |
| chloramphenicol | 100% n=70 | 100% n=79 | |||||
| Totals | 86.6% n=1103 | 88.1% n=1098 | 83.5% n=284 | 90.9% n=416 | 80.7% n=410 | 84.4% n=540 | |
This data is accurate as of: 11/22/2016 11:53:47 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: amoxicillin/clavulanate, vancomycin, cefaclor, cefuroxime, cefotaxime, erythromycin, azithromycin, levofloxacin, gatifloxacin, TMP/SMX, chloramphenicol, ampicillin, ceftriaxone, penicillin, clindamycin.
